Wedmont Private Capital’s DexCom DXCM Stock Holding History

Wedmont Private Capital’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$255K	Sell	3,406 -715	-17%	-$47.6K	0.01%	813
2026 Q1	$271K	Buy	+4,121	New	+$287K	0.01%	699
2025 Q3	–	Sell	-3,165	Closed	-$269K	–	798
2025 Q2	$269K	Sell	3,165 -66	-2%	-$5.17K	0.01%	616
2025 Q1	$214K	Buy	+3,231	New	+$264K	0.01%	636
2024 Q3	–	Sell	-5,107	Closed	-$583K	–	677
2024 Q2	$583K	Sell	5,107 -261	-5%	-$33K	0.04%	308
2024 Q1	$754K	Buy	5,368 +432	+9%	+$54.3K	0.06%	241
2023 Q4	$640K	Buy	4,936 +1,122	+29%	+$115K	0.05%	253
2023 Q3	$317K	Sell	3,814 -567	-13%	-$63.9K	0.03%	363
2023 Q2	$602K	Buy	4,381 +288	+7%	+$34.8K	0.06%	210
2023 Q1	$461K	Sell	4,093 -410	-9%	-$45.9K	0.06%	237
2022 Q4	$522K	Buy	4,503 +1,654	+58%	+$182K	0.08%	197
2022 Q3	$229K	Buy	+2,849	New	+$241K	0.05%	329
2022 Q2	–	Sell	-1,900	Closed	-$248K	–	350
2022 Q1	$248K	Buy	+1,900	New	+$208K	0.06%	272

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Wedmont Private Capital's DXCM Position: Q2 2026 in Review

Wedmont Private Capital reduced its DexCom (DXCM) stake by 17% in Q2 2026, selling an estimated $47.6K and leaving 3,406 shares worth $255K. The position accounts for 0.01% of the portfolio, ranked #813.

Wedmont Private Capital first reported a position in DXCM in Q1 2022 and has held it in 13 quarters since. The position peaked at $754K in Q1 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Wedmont Private Capital held 3,406 shares of DexCom worth $255K as of Q2 2026.
Wedmont Private Capital sold 715 DexCom shares in Q2 2026, an estimated $47.6K.
DexCom made up 0.01% of Wedmont Private Capital's portfolio in Q2 2026, its #813 holding.
Wedmont Private Capital first reported a position in DexCom in Q1 2022 and has held it in 13 quarters since.
Wedmont Private Capital's DexCom position peaked at $754K in Q1 2024.
968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Wedmont Private Capital's 13F filing for Q2 2026, filed 13 Jul 2026.